Who Is Buying Procter & Gamble? Hedge Fund Activity in 2026
See which hedge funds are buying, selling, or holding Procter & Gamble (PG) based on latest 13F filings. 10 funds buying — the strongest buy-side consensus in our coverage.
8 min czytaniaFact-checked against primary sources on · figures re-verified on regulator, issuer or SEC filings — not copied from other sites
Who Is Buying Procter & Gamble? Hedge Fund Activity in 2026
Procter & Gamble is the undisputed king of consumer staples — a $400+ billion empire built on brands that billions of people use every day. Tide, Pampers, Gillette, Crest, Bounty, Charmin, Head & Shoulders, Oral-B — the portfolio reads like a shopping list for everyday life. P&G's pricing power, global distribution network, and relentless brand investment have made it one of the most reliable dividend growers in stock market history, with 67+ consecutive years of dividend increases. In uncertain economic times, P&G is the ultimate defensive compounder.
The latest 13F filings reveal the strongest bullish consensus we've tracked this quarter: 10 funds are buying versus just 6 selling, with 4 holding steady across 20 tracked funds. This 10-to-6 ratio makes P&G one of the most heavily favored stocks among institutional investors.
Quick Answer
Across the funds we read directly from SEC filings, the largest Procter Gamble position in the Q2 2026 13Fs (period ending 30 June 2026) is Citadel Advisors at $426M (2,905,793 shares). Measured against the size of each filer's book rather than in dollars, the most concentrated holder is Citadel Advisors, where Procter Gamble is 0.2% of everything they report. Every figure here is aggregated by CUSIP from the filer's own information table with put/call rows excluded — a 13F lists options beside shares, and adding them together is what produces the inflated stakes quoted elsewhere. Filings lag roughly 45 days: this is positioning as of 30 June 2026, not today, and not investment advice.
Procter & Gamble Institutional Snapshot
| Metric | Value |
|---|---|
| Funds Buying | 10 |
| Funds Selling | 6 |
| Funds Holding | 4 |
| Active Funds Tracked | 20 |
A 10-to-6 buy-sell ratio is emphatically bullish. In our entire coverage universe of hundreds of stocks, very few command this level of institutional buying consensus. When half of all tracked funds are actively increasing positions, and another fifth are holding steady, it signals broad-based institutional conviction in P&G's investment case.
Savings in one bank, investments in another? See it all in one place — and how many months it could carry you.
See your Freedom Runway — freeWho holds Procter Gamble, and how much it matters to them
Read from each filer's Q2 2026 information table (period ending 30 June 2026).
| Fund | Position | Shares | Share of the fund's 13F book |
|---|---|---|---|
| Citadel Advisors | $426M | 2,905,793 | 0.2% of $171.84B |
| Millennium Management | $217M | 1,482,738 | 0.2% of $142.92B |
| Bridgewater Associates | $20M | 137,724 | 0.1% of $24.38B |
The last column is the one worth reading. A multi-strategy fund reporting a $100B+ book can hold a large dollar amount of Procter Gamble that means almost nothing to it, while a concentrated fund holding less in dollars may have several percent of its entire book in the name. Rankings by dollar value hide exactly that difference.
Who added and who cut
Comparing each filer's Q1 2026 table with its Q2 2026 one, by share count — the change is what shows conviction, not the size of the position.
| Fund | Q1 2026 shares | Q2 2026 shares | Change |
|---|---|---|---|
| Citadel Advisors | 685,435 | 2,905,793 | +324% |
| Millennium Management | 1,034,494 | 1,482,738 | +43% |
| Bridgewater Associates | 157,906 | 137,724 | -13% |
A fund absent from this table reported no Procter Gamble position in either quarter.
Related Articles
- Who Is Buying McDonald's? Hedge Fund Activity in 2026
- Who Is Buying Abbott Laboratories? Hedge Fund Activity in 2026
- Who Is Buying Chipotle? Hedge Fund Activity in 2026
FAQ
Why are hedge funds so bullish on Procter & Gamble in 2026?
P&G shows one of the strongest buy-sell ratios in our coverage, with 10 funds increasing positions versus 6 trimming. Institutional analysts cite P&G's pricing power, defensive consumer-staples profile, and dependable dividend growth as reasons it screens well in macro frameworks that favour quality compounders.
What does "dividend aristocrat" mean and why does it matter for PG?
A dividend aristocrat is an S&P 500 company that has raised its dividend for at least 25 consecutive years. P&G has increased its dividend for 67+ consecutive years, which creates structural demand from pension funds, endowments, and income-mandated institutional accounts that must hold reliable dividend growers.
How does P&G's pricing power show up in the institutional thesis?
P&G has demonstrated the ability to raise prices across categories like detergents, paper goods, and personal care without losing meaningful market share. In an inflationary environment, this pricing power makes earnings more predictable, which is why quant funds like D.E. Shaw, Renaissance, and Two Sigma all increased exposure simultaneously.
Why is the three-way quant consensus on PG considered unusual?
D.E. Shaw, Renaissance, and Two Sigma use very different models, datasets, and timeframes. When all three independently increase their PG positions in the same quarter — combined over $1.26 billion — it suggests the statistical case for the stock is robust across multiple analytical frameworks rather than dependent on a single signal.
Is this article financial advice on Procter & Gamble stock?
No. This page summarises publicly disclosed 13F filings for informational and educational purposes and does not constitute investment advice or a recommendation. Always review official filings and consult a licensed advisor before making any investment decision.